Peter M. Rothwell

85.7k total citations · 27 hit papers
549 papers, 45.8k citations indexed

About

Peter M. Rothwell is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter M. Rothwell has authored 549 papers receiving a total of 45.8k indexed citations (citations by other indexed papers that have themselves been cited), including 290 papers in Epidemiology, 270 papers in Pulmonary and Respiratory Medicine and 236 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter M. Rothwell's work include Acute Ischemic Stroke Management (287 papers), Cerebrovascular and Carotid Artery Diseases (239 papers) and Cardiovascular Health and Disease Prevention (116 papers). Peter M. Rothwell is often cited by papers focused on Acute Ischemic Stroke Management (287 papers), Cerebrovascular and Carotid Artery Diseases (239 papers) and Cardiovascular Health and Disease Prevention (116 papers). Peter M. Rothwell collaborates with scholars based in United Kingdom, United States and Germany. Peter M. Rothwell's co-authors include Sarah T. Pendlebury, Charles Warlow, Ziyah Mehta, Joanna Lovett, Ursula G. Schulz, Tom Meade, Matthew F. Giles, Linxin Li, Kittipan Rerkasem and J. J. F. Belch and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter M. Rothwell

537 papers receiving 44.4k citations

Hit Papers

External validity of randomised controlled trials: “To wh... 2004 2026 2011 2018 2005 2009 2010 2007 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. External validity of randomised controlled trials: “To whom do the results of this trial apply?”
    2005 1.7k citations Peter M. Rothwell The Lancet profile →
  2. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis
    2009 1.3k citations Sarah T. Pendlebury, Peter M. Rothwell profile →
  3. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
    2010 1.3k citations Peter M. Rothwell, Sally C. Howard et al. The Lancet profile →
  4. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
    2007 1.1k citations Peter M. Rothwell et al. profile →
  5. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
    2010 1.1k citations Peter M. Rothwell, Charles Warlow et al. The Lancet profile →
  6. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
    2010 990 citations Peter M. Rothwell, Charles Warlow et al. The Lancet profile →
  7. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack
    2007 874 citations Peter M. Rothwell et al. The Lancet profile →
  8. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison
    2007 805 citations Peter M. Rothwell, Caroline Lovelock et al. The Lancet profile →
  9. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
    2012 736 citations Peter M. Rothwell et al. The Lancet profile →
  10. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
    2005 654 citations Peter M. Rothwell The Lancet profile →
  11. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
    2012 628 citations Peter M. Rothwell et al. The Lancet profile →
  12. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
    2012 627 citations Peter M. Rothwell et al. profile →
  13. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services
    2004 569 citations Joanna Lovett, Peter M. Rothwell et al. profile →
  14. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
    2010 547 citations Alastair J.S. Webb, Peter M. Rothwell et al. The Lancet profile →
  15. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies
    2004 535 citations Joanna Lovett, Peter M. Rothwell et al. profile →
  16. Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control
    2013 522 citations Peter M. Rothwell et al. Circulation profile →
  17. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
    2010 521 citations Peter M. Rothwell The Lancet profile →
  18. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
    2018 515 citations Peter M. Rothwell et al. The Lancet profile →
  19. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
    2010 480 citations Peter M. Rothwell, Sally C. Howard et al. profile →
  20. Global Stroke Statistics
    2013 398 citations Peter M. Rothwell et al. International Journal of Stroke profile →
  21. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
    2016 374 citations Peter M. Rothwell et al. profile →
  22. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study
    2019 364 citations Sarah T. Pendlebury, Peter M. Rothwell profile →
  23. Global stroke statistics
    2016 338 citations Peter M. Rothwell et al. International Journal of Stroke profile →
  24. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study
    2015 291 citations Linxin Li, Ursula G. Schulz et al. profile →
  25. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
    2017 250 citations Linxin Li, Peter M. Rothwell et al. The Lancet profile →
  26. Global Stroke Statistics 2019
    2020 236 citations Peter M. Rothwell et al. International Journal of Stroke profile →
  27. Global stroke statistics 2022
    2022 155 citations Peter M. Rothwell et al. International Journal of Stroke profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Rothwell United Kingdom 109 17.9k 17.1k 16.4k 9.4k 5.0k 549 45.8k
Ralph L. Sacco United States 95 18.0k 1.0× 15.1k 0.9× 24.5k 1.5× 7.6k 0.8× 4.5k 0.9× 519 49.7k
Peter J. Koudstaal Netherlands 96 12.5k 0.7× 9.7k 0.6× 11.7k 0.7× 8.3k 0.9× 3.1k 0.6× 448 38.8k
Michael D. Hill Canada 97 22.6k 1.3× 12.4k 0.7× 10.3k 0.6× 10.8k 1.2× 3.8k 0.8× 938 43.4k
S. Claiborne Johnston United States 83 17.3k 1.0× 11.0k 0.6× 10.7k 0.7× 11.4k 1.2× 3.3k 0.7× 338 35.8k
Philip A. Wolf United States 128 14.7k 0.8× 10.9k 0.6× 37.2k 2.3× 5.8k 0.6× 7.6k 1.5× 343 74.7k
Larry B. Goldstein United States 76 12.8k 0.7× 7.9k 0.5× 8.2k 0.5× 5.2k 0.6× 3.6k 0.7× 397 27.9k
Graeme J. Hankey Australia 91 8.8k 0.5× 5.4k 0.3× 16.5k 1.0× 3.9k 0.4× 4.3k 0.9× 670 37.1k
Harold P. Adams United States 65 24.6k 1.4× 15.1k 0.9× 7.9k 0.5× 15.6k 1.7× 2.9k 0.6× 255 41.1k
Ale Algra Netherlands 97 11.8k 0.7× 11.7k 0.7× 7.8k 0.5× 24.2k 2.6× 3.6k 0.7× 536 42.7k
Martin Dennis United Kingdom 83 13.5k 0.8× 6.8k 0.4× 5.4k 0.3× 6.5k 0.7× 2.5k 0.5× 344 26.5k

Countries citing papers authored by Peter M. Rothwell

Since Specialization
Citations

This map shows the geographic impact of Peter M. Rothwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Rothwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Rothwell more than expected).

Fields of papers citing papers by Peter M. Rothwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Rothwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Rothwell. The network helps show where Peter M. Rothwell may publish in the future.

Co-authorship network of co-authors of Peter M. Rothwell

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Rothwell. A scholar is included among the top collaborators of Peter M. Rothwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Rothwell. Peter M. Rothwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Dearbhla, et al.. (2025). The Kidney-Immune-Brain Axis: The Role of Inflammation in the Pathogenesis and Treatment of Stroke in Chronic Kidney Disease. Stroke. 56(4). 1069–1081. 1 indexed citations
2.
Strain, W. David, Martin James, Lawrence A. Leiter, et al.. (2022). Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6. Stroke. 53(9). 2749–2757. 49 indexed citations
3.
4.
5.
Mehlum, Maria H., Knut Liestøl, Sverre E. Kjeldsen, et al.. (2020). Blood Pressure–Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers. Hypertension. 75(6). 1584–1592. 14 indexed citations
6.
Li, Linxin, et al.. (2020). Trends in Stroke Incidence in High-Income Countries in the 21st Century. Stroke. 51(5). 1372–1380. 101 indexed citations
7.
Markus, Hugh S., Susanna C. Larsson, John Dennis, et al.. (2019). Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Health Technology Assessment. 23(41). 1–30. 16 indexed citations
8.
9.
Barton, Pelham, James P Sheppard, Sue Jowett, et al.. (2017). When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study. BMJ Open. 7(11). e018189–e018189.
10.
Ohkuma, Toshiaki, Mark Woodward, Min Jun, et al.. (2017). Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus. Hypertension. 70(2). 461–468. 58 indexed citations
11.
Tuna, Assunção, et al.. (2015). Long-term risk of stroke and coronary events after focal and non-focal transient neurological attacks: A population-based study. International Journal of Stroke. 10. 52–52. 1 indexed citations
12.
Lasserson, Daniel, David Mant, Richard Hobbs, & Peter M. Rothwell. (2013). Validation of a TIA Recognition Tool in Primary and Secondary Care: Implications for Generalizability. International Journal of Stroke. 10(5). 692–696. 15 indexed citations
13.
Hata, Jun, Hisatomi Arima, Peter M. Rothwell, et al.. (2013). Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Circulation. 128(12). 1325–1334. 163 indexed citations
14.
Lovelock, Caroline, Charlotte Cordonnier, Hiromitsu Naka, et al.. (2010). Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage. Stroke. 41(6). 1222–1228. 207 indexed citations
15.
Lewis, Steff, Charles Warlow, Andrew Bodenham, et al.. (2008). General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. The Lancet. 372(9656). 2132–2142. 356 indexed citations
16.
Floßmann, Enrico & Peter M. Rothwell. (2004). Confounding of heritability of ischaemic stroke by hypertension and other intermediate phenotypes. Journal of Neurology Neurosurgery & Psychiatry. 35. 603–604. 1 indexed citations
17.
Naylor, A.R., Robert L. Cuffe, Peter M. Rothwell, & Peter Bell. (2003). A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. European Journal of Vascular and Endovascular Surgery. 25(5). 380–389. 178 indexed citations
18.
Lovett, Joanna, Sally C. Howard, & Peter M. Rothwell. (2003). Pulse pressure is independently associated with carotid plaque ulceration. Journal of Hypertension. 21(9). 1669–1676. 48 indexed citations
19.
Deeks, Jonathan J, et al.. (2002). 3rd symposium on Systematic Review Methodology - Preface. Statistics in Medicine. 21. 1501–1502. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph L. Sacco Breakdown of academic impact, for papers by Peter J. Koudstaal Breakdown of academic impact, for papers by Michael D. Hill Breakdown of academic impact, for papers by S. Claiborne Johnston Breakdown of academic impact, for papers by Philip A. Wolf Breakdown of academic impact, for papers by Larry B. Goldstein Breakdown of academic impact, for papers by Graeme J. Hankey Breakdown of academic impact, for papers by Harold P. Adams Breakdown of academic impact, for papers by Ale Algra Breakdown of academic impact, for papers by Martin Dennis
Rankless by CCL
2026